Last reviewed · How we verify
Quick-Acting Heart Reliever — Competitive Intelligence Brief
marketed
Cardiovascular
Small molecule
Live · refreshed every 30 min
Target snapshot
Quick-Acting Heart Reliever (Quick-Acting Heart Reliever) — Guang'anmen Hospital of China Academy of Chinese Medical Sciences. Quick-Acting Heart Reliever is a traditional Chinese medicine formulation designed to rapidly relieve acute cardiac symptoms through multi-component herbal action.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Quick-Acting Heart Reliever TARGET | Quick-Acting Heart Reliever | Guang'anmen Hospital of China Academy of Chinese Medical Sciences | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Quick-Acting Heart Reliever CI watch — RSS
- Quick-Acting Heart Reliever CI watch — Atom
- Quick-Acting Heart Reliever CI watch — JSON
- Quick-Acting Heart Reliever alone — RSS
Cite this brief
Drug Landscape (2026). Quick-Acting Heart Reliever — Competitive Intelligence Brief. https://druglandscape.com/ci/quick-acting-heart-reliever. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing